Current Management Strategy of Nasopharyngeal Carcinoma
Authors:
Open Access
- 1 January 2010
- journal article
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 3 (1) , 1-12
Abstract
Nasopharyngeal carcinoma is an unique head and neck cancer. It is common among the southern Chinese and is closely associated with the Epstein Barr virus (EBV). To diagnose the disease in its early stage is infrequent as the symptoms are usually trivial and patients only present in late stages. Testing the blood for elevated EBV DNA has now become a screening test for the high risk group of patients, aiming to diagnose the disease in its early stages. Imaging studies, positron emission tomography scans in addition to clinical examination provide information on the extent of the disease. The confirmation of the disease still depends on endoscopic examination and biopsy. Radiotherapy with or without chemotherapy has been the primary treatment modality. The application of intensity modulated radiotherapy and the use of concomitant chemoradiation have improved the control of nasopharyngeal carcinoma together with the reduction of long term side effects. The early detection of residual or recurrence tumor in the neck or at the primary site has allowed delivery of salvage treatment. The choice of the optimal surgical salvage, either for neck disease or primary tumor depends on the extent of the residual or recurrent disease. The outcome of these patients have improved with the application of the appropriate surgical salvage.Keywords
This publication has 149 references indexed in Scilit:
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinomaThe Laryngoscope, 2009
- Preservation of quality of life after intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma: Results of a prospective longitudinal studyHead & Neck, 2006
- Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinomaClinical Oral Investigations, 2003
- 18‐Fluoro‐2‐deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imagingCancer, 2003
- Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal CarcinomaJNCI: Journal of the National Cancer Institute, 2002
- Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective studyHead & Neck, 1999
- Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985: late complications following megavoltage irradiationBritish Journal of Radiology, 1992
- Role of Bone Scanning in Detection of Subclinical Bone Metastasis in Nasopharyngeal CarcinomaClinical Nuclear Medicine, 1991
- Nasopharyngeal carcinomaBritish Journal of Surgery, 1941